Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02336165
What this trial is testing

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Who this might be right for
Glioblastoma
Ludwig Institute for Cancer Research 159
Large-scale testing (Phase 3)Study completedNCT01811121
What this trial is testing

MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS

Who this might be right for
Glioblastoma
Hospices Civils de Lyon 170
Large-scale testing (Phase 3)WithdrawnNCT00083447
What this trial is testing

Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Xenova Biomedix 323
Testing effectiveness (Phase 2)Study completedNCT00006093
What this trial is testing

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120284
What this trial is testing

Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
University of Florida 40
Testing effectiveness (Phase 2)Study completedNCT03277638
What this trial is testing

Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)

Who this might be right for
Glioblastoma, Adult
Case Comprehensive Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT02478164
What this trial is testing

Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma

Who this might be right for
Glioblastoma
Dana-Farber Cancer Institute 17
Early research (Phase 1)Study completedNCT00784914
What this trial is testing

A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
City of Hope Medical Center 12
Early research (Phase 1)Study completedNCT01475006
What this trial is testing

AMG 595 First-in-Human in Recurrent Gliomas

Who this might be right for
Advanced Malignant GliomaAnaplastic AstrocytomasGlioblastoma Multiforme
Amgen 32
Early research (Phase 1)Study completedNCT01390571
What this trial is testing

Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Cancer Research UK 34
Large-scale testing (Phase 3)Not Yet RecruitingNCT07349693
What this trial is testing

Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma, IDH-Wildtype
Everfront Biotech Co., Ltd. 175
Testing effectiveness (Phase 2)Study completedNCT00352521
What this trial is testing

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 20
Testing effectiveness (Phase 2)UnknownNCT06279767
What this trial is testing

Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma

Who this might be right for
GlioblastomaCancerTemozolomide
The First Affiliated Hospital with Nanjing Medical University 27
Not applicableNo Longer AvailableNCT05936216
What this trial is testing

TVI-Brain-1 in Expanded Access Patient

Who this might be right for
Recurrent Glioblastoma
TVAX Biomedical
Early research (Phase 1)Study completedNCT03128047
What this trial is testing

HUMC 1612: Optune NovoTTF-200A System

Who this might be right for
High Grade GliomaEpendymoma
Hackensack Meridian Health 7
Testing effectiveness (Phase 2)Ended earlyNCT01666600
What this trial is testing

NOA-12: BIBF1120 and R-RT in Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Prof. Dr. Wolfgang Wick 63
Testing effectiveness (Phase 2)Study completedNCT00112736
What this trial is testing

Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+8 more
National Cancer Institute (NCI) 69
Not applicableLooking for participantsNCT07832734
What this trial is testing

Metabolomics and Transcriptomics of Low- and High-Grade Gliomas

Who this might be right for
IDH Wildtype GlioblastomaIDH Mutant Lower-Grade Gliomas
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 220
Testing effectiveness (Phase 2)Ended earlyNCT01186406
What this trial is testing

Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma MultiformeGliosarcoma
Duke University 41
Not applicableStudy completedNCT05735171
What this trial is testing

Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence

Who this might be right for
Glioblastoma
Hospital del Rio Hortega 20
Next Page